Actavis plc Ordinary Shares (NYSE:ACT)’s Price Target Increased

1887

Dallas, Texas 03/28/2014 (FINANCIALSTRENDS) – Argus has upped their target price on Actavis plc Ordinary Shares (NYSE:ACT) shares from $198.00 up to $225.00 in the research note that was issued to investors. Argus’ PT indicates the potential downside of 0.99 percent from Actavis plc Ordinary Shares (NYSE:ACT)’s current price. Recently, numerous equities-research analysts have issued their reports about the company stock. Analysts at the RBC Capital firm have raised their PT on Actavis plc Ordinary Shares (NYSE:ACT) shares from $240.00 up to $249.00 in the  research note on  21 February. They currently have a rating of “outperform”  on the Actavis plc Ordinary Shares (NYSE:ACT) stock.

Separately, Barclays analysts have upped their price-target on Actavis plc Ordinary Shares (NYSE:ACT) shares from $230.00 up  to $250.00 in the research note on 19 February . They now have a rating of an “overweight” on the stock. Finally, the analysts at the UBS AG have  raised the price target on Actavis plc Ordinary Shares (NYSE:ACT) shares from $202.00 up  to $237.00 in the research note on 19 February. They have now set a rating of  “buy” on the stock. Five equities-research analysts have rated the Actavis plc Ordinary Shares (NYSE:ACT) stock with a “hold” rating and 14  have assigned a “buy” rating to the Actavis plc Ordinary Shares (NYSE:ACT) stock. Currently, the average rating on the company is a “buy” and the average price target is $193.18.

Actavis plc Ordinary Shares (NYSE:ACT) last announced the company’s earnings-results on 20 February . It  reported earnings per share of $3.17 for the quarter, which topped the average analysts’ projections of $3.05 by $0.12. Actavis plc Ordinary Shares (NYSE:ACT) reported revenue of $2.78B for the quarter, in comparison to the average projection  of $2.68 billion. On and average, analysts project  that Actavis plc Ordinary Shares (NYSE:ACT) will post earnings per share of $13.02 for the current financial year.